Navigation Links
Ira Haimowitz, PhD, EVP, at The CementBloc, to Present on Best Practices in iPad Interactive Selling at 11th Annual ePharma Summit™
Date:1/26/2012

NEW YORK, Jan. 26, 2012 /PRNewswire/ -- Dr. Ira J. Haimowitz, Executive Vice President, Group Director, Intelligence and Analytics, at The CementBloc, will be a featured presenter at the eMarketing University for Brand Managers, a symposium at the ePharma Summit in New York City on February 6, 2012.

The symposium is a full-day course designed for those in pharmaceutical product management seeking to incorporate digital tactics into their marketing mix. Dr. Haimowitz will be presenting on the benefits of transitioning to closed-loop, iPad-based detailing. His talk is entitled, "Transforming Your Organization Through Interactive Selling." He will bring to the symposium his unique expertise in the use of technology in pharmaceutical sales and marketing.

"Selling with an iPad represents a cultural shift," explains Dr. Haimowitz. "It is critical to ensure processes are in place to rapidly respond to changing market needs and keep content fresh. This kind of agility will require the commitment and active participation by several groups of stakeholders: sales and sales leadership, sales operations, sales training, marketing, marketing science and market research, IT, medical/legal/regulatory, and potentially sourcing and vendor management."

For over 20 years, Dr. Haimowitz has provided healthcare clients with innovative solutions for relationship marketing, segmentation, operations, measurement, and optimization. He has also enabled clients to evaluate the return on investment of their multichannel consumer and professional advertising campaigns.

Prior to joining The CementBloc, Dr. Haimowitz spent nearly 10 years on the manufacturer side as a Director and Team Leader in marketing and sales operations and analytics for pharmaceutical companies Pfizer and Organon. He then served as Vice President, Group Director of Insights and Optimization, at Wunderman, leading a team deploying analytics across healthcare, financial services, and consumer packaged goods.

Dr. Haimowitz received his PhD in computer science from the Massachusetts Institute of Technology in 1994, and his MPhil from Cambridge University in computer speech and language processing. He has spoken and published extensively, and has also served for 7 years on the board of the Pharmaceutical Management Science Association, including a term as President in 2006. Dr. Haimowitz recently authored the book Healthcare Relationship Marketing, from Gower Press, and has a blog by the same name (http://healthcarerm.blogspot.com/).

To register for the ePharma Summit, call 888-670-8200.

About The CementBloc: The CementBloc is a leading multichannel health and wellness creative agency based in New York. Founded in 2000 by Susan Miller Viray and Rico Viray, The CementBloc is also a founding member of Indigenus, an independent global network of entrepreneurial healthcare creative agencies.

http://www.thecementbloc.com


'/>"/>
SOURCE The CementBloc
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ira Haimowitz, PhD, EVP, Group Director, Intelligence and Analytics at The CementBloc, to Present at Aberdeen Group Inaugural Business Analytics Summit
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
9. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
10. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
11. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016  Consumers have taken a more active ... more emphasis on patient outcomes. ... the pharmaceutical industry have evolved beyond just providing ... are focusing on becoming more patient-oriented across their ... services that improve health. ...
(Date:6/24/2016)... N.J. , June 24, 2016  Collagen ... the design, development and manufacturing of collagen and ... regeneration announced today that Bill Messer ... and Marketing to further leverage the growing portfolio ... medical devices. Bill joins the Collagen ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... pluripotent stem (iPS) cells and other difficult to transfect cells, announces its launch ... PluriQ™ G9™ Gene Editing System is a complete system for culturing ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, InhaleLabs.com ... ingestion of their medication by matching users with high quality water pipes within an ... with no commitment. , Inhale was founded by two brothers, Nick and Mike Hunter, ...
(Date:6/23/2016)... ... June 23, 2016 , ... vcfo, a consulting firm ... pleased to announce the promotion of Mike Mackey to Regional Vice President of ... he was responsible for managing client projects and overseeing vcfo financial consultants in ...
Breaking Medicine News(10 mins):